Andere Kunden interessierten sich auch für
![Examining the State of the Science of Mammalian Embryo Model Systems]( "Examining the State of the Science of Mammalian Embryo Model Systems")
Examining the State of the Science of Mammalian Embryo Model Systems67,99 €![Biomarkers for Traumatic Brain Injury]( "Biomarkers for Traumatic Brain Injury")
Biomarkers for Traumatic Brain Injury21,99 €![Multimodal Biomarkers for Central Nervous System Disorders]( "Multimodal Biomarkers for Central Nervous System Disorders")
Multimodal Biomarkers for Central Nervous System Disorders21,99 €![Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease]( "Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease")
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease67,99 €![Biomarkers of Neuroinflammation]( "Biomarkers of Neuroinflammation")
Biomarkers of Neuroinflammation57,99 €![Accelerating the Use of Findings from Patient-Centered Outcomes Research in Clinical Practice to Improve Health and Health Care]( "Accelerating the Use of Findings from Patient-Centered Outcomes Research in Clinical Practice to Improve Health and Health Care")
Accelerating the Use of Findings from Patient-Centered Outcomes Research in Clinical Practice to Improve Health and Health Care28,99 €![The Clinical Utility of Compounded Bioidentical Hormone Therapy]( "The Clinical Utility of Compounded Bioidentical Hormone Therapy")
The Clinical Utility of Compounded Bioidentical Hormone Therapy89,99 €
As part of the overall disability determination process, the Social Security Administration uses a step-by-step approach to understand how severe an individual's condition is and whether it meets program criteria for disability. The use of various types of biomarkers has been suggested as a way to strengthen the amount and quality of objective evidence available to the review process. At the request of the Social Security Administration, the National Academies of Sciences, Engineering, and Medicine's Board on Health Care Services organized a virtual workshop on July 21, 2020, titled The State of the Science of the Use of Biomarkers to Establish the Presence and Severity of Impairments. Workshop discussions focused on the current and potential uses for biomarkers; explored legal and ethical implications associated with biomarker use in clinical decision making; and considered the possible uses of nongenetic biomarkers as tools for the diagnosis or prognosis of the severity of specific physical and mental impairments. This publication summarizes the presentations and discussion of the workshop.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.